Effects and mechanisms of nutritional interventions on extradigestive complications in obese patients

Table 6 Receiver operating characteristic curve analysis of the serum levels of platelet endothelial cell adhesion molecule-1, growth differentiation factor 11, and fibroblast growth factor 21 in predicting the occurrence of extradigestive complications in patients with obesity

Indicators	Cut-of value	AUC (95%CI)	Sensitivity	Specificity	Jordon index
PECAM-1	40 μg/L	0.798 (0.595-0.974)	0.824	0.744	0.568
GDF11	650 μg/L	0.716 (0.509 -0.929)	0.716	0.733	0.449
FGF21	160 ng/L	0.813 (0.671-0.940)	0.811	0.791	0.602
Tripartite		0.909 (0.850-0.958)	0.919	0.884	0.803

AUC: Area under the curve; CI: Confidenceinterval; PECAM-1: Platelet endothelial cell adhesion molecule-1; GDF11: Growth differentiation factor 11; FGF21: Fibroblast growth factor 21.